Weifeng Ding | Pancreatic Cancer | Best Researcher Award

Prof. Dr. Weifeng Ding | Pancreatic Cancer | Best Researcher Award

Affiliated Hospital of Nantong University | China

Author Profile

Scopus

📚 EARLY ACADEMIC PURSUITS

Dr. Ding Weifeng embarked on his academic journey with a strong foundation in medical laboratory science. His dedication to excellence and a deep interest in clinical research paved the way for advanced education, culminating in a Ph.D. His academic rigor was further enriched during his tenure as a Senior Visiting Scholar at the University of Texas Health Science Center (UTH) in the United States, where he gained international exposure and expertise.

🏆 PROFESSIONAL ENDEAVORS

Currently, Dr. Ding serves as the Deputy Director of the Department of Clinical Laboratory at the Affiliated Hospital of Nantong University and the Deputy Director of the Department of Laboratory Medicine at Nantong University. He holds dual roles as Chief Technologist, Associate Professor, and Master’s Supervisor, combining practical expertise, teaching, and mentorship in his field.

His professional career reflects significant recognition as a high-level talent under Jiangsu Province's "333" Project, a leading figure in Nantong City's "226" Project, and a key young medical talent in Jiangsu Province.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON PANCREATIC CANCER

Dr. Ding's research expertise spans medical laboratory science, with significant contributions in:

  • Advancing laboratory diagnostics.
  • Innovating approaches to translational medicine and molecular techniques.

He has successfully led three National Natural Science Foundation projects, a China Postdoctoral Science Foundation project, and seven provincial and municipal research projects. These projects demonstrate his ability to bridge clinical applications and theoretical research.

🌍 IMPACT AND INFLUENCE

Dr. Ding has gained widespread recognition for his contributions to scientific research, including the:

  • Third Prize of Jiangsu Medical Science and Technology Award
  • Second Prize of Nantong Science and Technology Progress Award
  • Nantong Youth Science and Technology Award

His achievements underscore his impact on the fields of clinical practice and scientific innovation.

📈 ACADEMIC CITATIONS AND SCHOLARLY IMPACT

Dr. Ding has authored nearly 30 SCI-indexed papers as the first or corresponding author, reflecting his leadership and originality in research. Furthermore, his five Chinese invention patents attest to his contributions to technological advancements in medical diagnostics.

🌟 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Ding’s dedication to medical laboratory science has left a lasting legacy in education, innovation, and clinical practice. He actively fosters the next generation of professionals through mentorship and collaboration while pushing the frontiers of translational medicine and diagnostic technology.

In the years ahead, he is expected to:

  • Strengthen collaborations across global institutions.
  • Expand research projects in cutting-edge medical technologies.
  • Continue mentoring aspiring professionals in the medical laboratory field.

🌐 ENGAGEMENT IN ACADEMIC ORGANIZATIONS

Dr. Ding is actively involved in professional communities:

  • Standing Committee Member of the Abdominal Tumor Comprehensive Rehabilitation Branch, China Medical Education Association.
  • Committee Member of the Translational Medicine Professional Committee, Jiangsu Immunology Society.
  • Member of the Clinical Molecular Group, Jiangsu Medical Association Laboratory Medicine Branch.

📑NOTABLE PUBLICATIONS 

"Combined ultrasound endoscopy-guided fine-needle aspiration with DNA methylation of SHOX2 and RASSF1A genes to enhance the auxiliary diagnostic precision of pancreatic cancer

  • Authors: Shan, Y. , Teng, Y. , Guan, C. , Ding, W. , Zhang, J.
  • Journal: Heliyon
  • Year: 2024

"DNA methylation modulates epigenetic regulation in colorectal cancer diagnosis, prognosis and precision medicine

  • Authors: Ye, J., Zhang, J., Ding, W.
  • Journal: Exploration of Targeted Anti-tumor Therapy
  • Year: 2024

"Retraction Note: Targeting of colorectal cancer growth, metastasis, and anti-apoptosis in BALB/c nude mice via APRIL siRNA (Molecular and Cellular Biochemistry

  • Authors: Wang, J. , Ding, W. , Sun, B. , Shi, G. , Wang, H.
  • Journal: Molecular and Cellular Biochemistry
  • Year: 2023

"DNA hypermethylation contributes to colorectal cancer metastasis by regulating the binding of CEBPB and TFCP2 to the CPEB1 promoter

  • Authors: Shao, K. , Pu, W. , Zhang, J. , Zhang, Z. , Ding, W.
  • Journal: Clinical Epigenetics
  • Year: 2021

"Targeted Bisulfite Sequencing Reveals DNA Methylation Changes in Zinc Finger Family Genes Associated With KRAS Mutated Colorectal Cancer

  • Authors: Pu, W. , Qian, F. , Liu, J. , Ju, S. , Ding, W.
  • Journal: Frontiers in Cell and Developmental Biology
  • Year: 2021

Anish Maskey | Staphylococcus Aureus | Best Researcher Award

Dr. Anish Maskey | Staphylococcus Aureus | Best Researcher Award

New York Medical College | United States

Author Profile

Scopus

Orcid ID

Google Scholar

🌟 Dr. Anish R. Maskey, Ph.D. - Postdoctoral Fellow and Immunology Innovator

📚 EARLY ACADEMIC PURSUITS

Dr. Anish R. Maskey's academic journey began in Kathmandu, Nepal, where he earned a Bachelor of Science in 2016 from the Institute of Medicine. With a robust foundation in science, he pursued a Ph.D. in Pathology, Microbiology, and Immunology at New York Medical College, achieving an impressive CGPA of 3.75/4. His early education set the stage for a distinguished career in immunology, preparing him to tackle complex health challenges with innovative research approaches.

🧪 PROFESSIONAL ENDEAVORS

Currently a Postdoctoral Fellow in the Department of Pathology, Microbiology, and Immunology at New York Medical College, Dr. Maskey is mentored by Dr. Xiu-Min Li and focuses on pioneering research in immunology. His professional roles have spanned several collaborative and high-impact projects, including co-investigating clinical biomarker studies and leading efforts in immuno-oncology research related to chronic inflammatory and infectious diseases. Dr. Maskey’s work is characterized by his adept handling of sophisticated scientific techniques and a commitment to developing therapeutic strategies for challenging medical conditions.

🔬 CONTRIBUTIONS AND RESEARCH FOCUS ON STAPHYLOCOCCUS AUREUS

Dr. Maskey's research contributions are extensive, with key focuses including:

  • B and T Cell Immunology: He has a deep-rooted expertise in investigating immune responses, particularly in relation to B and T cell functions in chronic inflammatory diseases and immuno-oncology.
  • Biomarker Studies in Allergy and Inflammation: His work on Traditional Chinese Medicine (TCM) involves understanding immune response markers in allergic diseases, the role of cytokines, and immune regulation, potentially offering new therapies for conditions such as eczema and food allergies.
  • Natural Compounds Against Antibiotic-Resistant Bacteria: In his role as Co-Principal Investigator, he has advanced research into natural compounds to combat antibiotic-resistant Staphylococcus aureus in both murine and humanized models.
  • Nanoparticle Immunotherapy: Dr. Maskey's study of berberine nanoparticles is pivotal in food allergy research, exploring mechanisms to suppress IgE-mediated allergic responses.

🌍 IMPACT AND INFLUENCE

Dr. Maskey's influence extends beyond the lab. His dedication to innovative research has earned him recognition through numerous awards, such as the AAAAI Ph.D. Travel Scholarships (2022-2024), the ASBMB Travel Award, and commendations for his scientific presentations. His involvement in conferences has facilitated cross-border collaborations, particularly between the U.S., India, and China, emphasizing his commitment to global health solutions. He is actively involved with organizations like the American Society for Microbiology and the American Academy of Allergy, Asthma, and Immunology, reflecting his dedication to community and professional engagement in the immunology field.

📈 ACADEMIC CITATIONS AND PUBLICATIONS

With his research published in high-impact journals, Dr. Maskey's contributions to immunology are recognized and respected. He has authored numerous papers and serves as a peer reviewer for journals like The FASEB Journal, Cell Press, and Dove Medical Press. His scholarly output includes first-author publications, institutional presentations, and national conference contributions, underscoring his commitment to advancing immunology research.

🏅 HONORS & AWARDS

  • AAAAI Ph.D. Travel Scholarship (2022-2024)
  • Outstanding Abstract Award at Touro Research Day (2024)
  • Science in a Flash Runner-Up by ASBMB (2022)
  • Outstanding Scientific Poster at MIT's Future of Health Technology Summit (2019)

🌐 LEGACY AND FUTURE CONTRIBUTIONS

Dr. Maskey’s legacy in immunology is still unfolding, with his promising work paving the way for future advancements in immunotherapy and natural medicine. His research on TCM, immune biomarkers, and nanoparticle technology is expected to yield novel treatment methods for allergies, chronic inflammation, and infectious diseases. Additionally, his role as a mentor to young scientists and his involvement in developing educational materials ensure his impact will resonate through future generations of researchers and clinicians.

🌠 FINAL NOTE

Dr. Anish R. Maskey embodies the spirit of a dedicated scientist and innovator, leveraging his expertise to improve human health. His work in immunology and microbiology is not only a testament to his skill but also his passion for creating lasting changes in medicine and science. With a promising future, Dr. Maskey continues to contribute meaningfully to the scientific community and inspire his peers and students alike.

📑 NOTABLE PUBLICATIONS 

"Berberine Inhibits the Inflammatory Response Induced by Staphylococcus aureus Isolated from Atopic Eczema Patients via the TNF-α/Inflammation/RAGE Pathways" 

  • Authors: Maskey, A.R. , Kopulos, D. , Kwan, M. , Geliebter, J. , Li, X.-M.
  • Journal: Cells
  • Year: 2024

"Preclinical Models of Atopic Dermatitis Suitable for Mechanistic and Therapeutic Investigations" 

  • Authors: Maskey, A.R. , Mo, X. , Li, X.-M.
  • Journal: Journal of Inflammation Research
  • Year: 2024

"The Efficacy & Molecular Mechanisms of a Terpenoid Compound Ganoderic Acid C1 on Corticosteroid-Resistant Neutrophilic Airway Inflammation: In vivo and in vitro Validation" 

  • Authors: Wang, Z.-Z. , Li, H. , Maskey, A.R. , Sampson, H.A. , Li, X.-M.
  • Journal: Journal of Inflammation Research
  • Year: 2024

"Sustained silencing peanut allergy by xanthopurpurin is associated with suppression of peripheral and bone marrow IgE-producing B cell" 

  • Authors: Yang, N. , Srivastava, K. , Chen, Y. , Zhan, J. , Li, X.-M.
  • Journal: Frontiers in Immunology
  • Year: 2024

"Inhibition of pathologic immunoglobulin E in food allergy by EBF-2 and active compound berberine associated with immunometabolism regulation" 

  • Authors: Yang, N. , Maskey, A.R. , Srivastava, K. , Sampson, H.A. , Li, X.-M.
  • Journal: Frontiers in Immunology
  • Year: 2023

Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

Dr. Ofon Elvis Amih | Infectious Diseases | Best Researcher Award

University of Buea | Cameroon

Author Profile

Scopus

Biography of Dr. Ofon Elvis Amih 🌍🧬

EARLY ACADEMIC PURSUITS 🎓

Dr. Ofon Elvis Amih’s academic journey is rooted in his commitment to biochemistry, starting with his undergraduate studies at the University of Dschang, Cameroon. From 2006 to 2010, he pursued a Bachelor of Science in Biochemistry with a specialty in Clinical Biochemistry. His passion for this field led him to continue his studies at the same institution, where he earned a Master of Science in Biochemistry between 2010 and 2013, further specializing in Clinical Biochemistry. In 2014, Dr. Amih embarked on his doctoral studies, culminating in a PhD in Biochemistry with a specialty in Clinical Biochemistry from the University of Dschang in 2019. His doctoral research solidified his expertise in biochemistry and set the stage for his future contributions to the field.

PROFESSIONAL ENDEAVORS AND TEACHING 📚

Dr. Amih’s career in academia began at the University of Dschang, where he served as a Graduate Teaching Monitor from 2014 to 2021. In this role, he assisted in tutorials, practical lessons, and exam invigilation. His teaching career advanced further when he joined the University of Buea as an Assistant Lecturer at the Faculty of Health Sciences in October 2021. His work at the University of Buea involves mentoring students and imparting valuable knowledge in the field of biochemistry. In addition to teaching, Dr. Amih engaged in postdoctoral research with the TrypanoGEN+ Consortium from 2019 to 2022, where he worked on groundbreaking research related to genome-wide association studies (GWAS). Furthermore, he became a Bioinformatics Fellow with H3Abionet/H3Africa, contributing to the intersection of bioinformatics and biochemistry through collaborative projects across Africa.

CONTRIBUTIONS AND RESEARCH FOCUS ON INFECTIOUS DISEASES🔬

Dr. Amih's research is deeply focused on the genetic markers associated with Human African Trypanosomiasis (HAT). His manuscript, currently in press, titled "A Genome-wide association study reveals novel genetic markers associated with Human African Trypanosomiasis," marks a significant contribution to understanding this tropical disease. His research work bridges biochemistry and bioinformatics, with an emphasis on using advanced genomic tools to address pressing health issues in Africa.

IMPACT AND INFLUENCE 🌟

Dr. Amih has had a considerable influence in his field, particularly through his involvement in internationally recognized initiatives like the TrypanoGEN+ Consortium and H3Abionet/H3Africa. His contributions extend beyond research, as he is also shaping future generations of scientists and biochemists through his academic roles. His work has impacted the global scientific community, with his insights contributing to scientific journals and conferences worldwide. He has actively participated in numerous workshops and conferences, from local events in Cameroon to international collaborations, such as the H3ABioNet Online ‘Introduction to Bioinformatics’ training course in South Africa.

ACADEMIC CITATIONS AND PUBLICATIONS🏅

Dr. Amih’s academic impact is further validated by his involvement in journal review activities for reputable publications such as Plos Computational Biology and the Journal of Bioscience and Medicine. His own manuscripts, particularly the upcoming publication on genetic markers for Human African Trypanosomiasis, are anticipated to contribute valuable citations in the field of clinical biochemistry and tropical disease research.

LEGACY AND FUTURE CONTRIBUTIONS 🔮

As Dr. Amih continues his academic and research endeavors, his legacy is likely to be defined by his contributions to both biochemistry and bioinformatics. His ongoing role at the University of Buea, coupled with his research collaborations across Africa, ensures that his work will leave a lasting impact on the scientific community, particularly in the areas of neglected tropical diseases and genetic research. Looking ahead, Dr. Amih is poised to expand his contributions through more collaborative research projects, potentially leading future generations of scientists and continuing to address critical health challenges in Africa. His deep expertise in both biochemistry and bioinformatics uniquely positions him as a leader in these intertwined disciplines.

NOTABLE PUBLICATIONS 📑

"High Levels of Genetic Diversity within Nilo-Saharan Populations: Implications for Human Adaptation" 

  • Authors: Mulindwa, J., Noyes, H., Ilboudo, H., Ahouty, B., & Kabore, J.
  • Journal: Human Genetics
  • Year: 2020

"Copy number variation in human genomes from three major ethno-linguistic groups in Africa" 

  • Authors: Nyangiri, O.A. , Noyes, H. , Mulindwa, J. ,Hertz-Fowler, C. , Matovu, E.
  • Journal: Genomics
  • Year: 2020

"Molecular identification of different trypanosome species in tsetse flies caught in the wildlife reserve of Santchou in the western region of Cameroon"

  • Authors: Kamdem, C.N. , Tiofack, A.A.Z. , Mewamba, E.M. , Gomseu, E.B.D. , Simo, G.
  • Journal: Parasitology Research
  • Year: 2020

"Association between polymorphisms of IL4, IL13, IL10, STAT6 and IFNG genes, cytokines and immunoglobulin E levels with high burden of Schistosoma mansoni in children from schistosomiasis endemic areas of Cameroon"

  • Authors: Mewamba, E.M. , Noyes, H. , Tiofack, A.A.Z. , MacLeod, A. , Simo, G.
  • Journal: Genetics and Evolution
  • Year: 2023

"Evaluation of ITS1 rDNA primers for the detection and identification of African trypanosomes in mammalian hosts and tsetse flies."

  • Authors: Ofon, E.A. , Metiadjoue, M.C.C. , Kante, S.T. ,Fogue, S.P. , Simo, G.
  • Journal: Acta Tropica
  • Year: 2024